Professor Hanne Mørck Nielsen´s research is focused on drug delivery of biotherapeutics. Her work is interdisciplinary and involves designing and characterizing functional excipients and drug delivery systems and understanding their delivery propensity related to interactions with biobarriers such as mucus and epithelia, and how this translates to therapeutic responses. Her work on drug delivery of antimicrobials to the respiratory tract comprise the design of nanoparticles loaded both the therapeutic agent as well as functional excipients, assessing their antimicrobial efficacy, and their interactions with biological barriers employing a range of biophysical methods.
Hanne Mørck Nielsen completed her PhD in Pharmaceutical Sciences on buccal drug delivery of peptides on research conducted at the Royal Danish School of Pharmacy, Denmark and Leiden/Amsterdam Center for Drug Research, the Netherlands. After a post doc at ETH Zürich, Switzerland working on cell-penetrating peptides, she was employed at the University of Copenhagen and in 2016 promoted to full Professor in Biopharmaceuticals – Drug Design and Delivery. She heads the BioDelivery Center and the Drug Delivery and Biophysics of Biopharmaceuticals group at Department of Pharmacy, University of Copenhagen. Hanne Mørck Nielsen has provided significant contributions to educating pharmaceutical scientists and a significant track record in drug delivery. She is on the editorial board of Journal of Controlled Release and Frontiers in Drug Delivery. Hanne Mørck Nielsen has published more than 175 papers in international scientific journals and educated more than 25 PhD students.
